2 Underrated Biotech Stocks to Buy Now
The year 2020 has truly been a roller-coaster ride for the stock market. After falling to extreme lows in mid-March as the coronavirus pandemic took hold, the market reached incredible highs on Nov. 24. The Dow Jones Industrial Average crossed the 30,000 mark for the first time ever, while the S&P 500 (SNPINDEX: ^GSPC) also marked its all-time closing high. However, both indexes retreated on Nov. 25, after the release of worsening U.S. jobless claims data.
In such a volatile market, it is quite difficult to find reasonably safe and high-growth biotech stocks. But there are two names that do fit the bill. Leading rare-disease player Alexion Pharmaceuticals (NASDAQ: ALXN) and neuropsychiatric disorder specialist Intra-Cellular Therapies (NASDAQ: ITCI) are both poised for an upward trajectory in coming months.
Image source: Getty Images.
Source Fool.com
